Ventricular Assist Devices Market Trends

  • Report ID: 1410
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Ventricular Assist Devices Market Trends

Growth Drivers

  • Growing Cases of Heart Attacks to Boost the Market Growth- For instance, approximately 0.08 million die every year in the United States alone.A heart attack or a myocardial infarction is a condition when the blood flow gets disrupted in a certain heart muscle. Such blockage of blood results in severe damage to the heart that can cause death or the lifetime functionality of the heart. Since ventricular assist devices are helpful to pump blood conveniently to the body, cardiologists prefer them more often. Hence, such a requirement is projected to propel the growth of the market over the forecast period.
  • Rising Penetration of Stroke Owing to Increasing Obesity Issues- It is observed that in every 5 adults, 1 of them dies on account of a stroke under the age of 25.
  • Increasing Prevalence of Coronary Artery Disease with Growing Changes in Food Habits- As of 2020, coronary heart disease was projected to account for approximately 0.35 million deaths across the globe.
  • Significant Utilization in the Treatment of Cardiac Arrhythmia Owing to Rising Disposable Income- In 2021, cardiac arrhythmia was estimated to be affecting between 5-12 million individuals globally.
  • Long Waiting Periods Associated with Heart Surgeries or Transplants - As per the Health Resources and Administration of the U.S. in 2018, 3980 candidates were included on the waiting list for heart surgeries.

Challenges

  • High Cost Associated with Requisite Equipment The equipment used is very expensive which a small clinic cannot afford. The high cost of maintenance and increasing hospitalization cost for these devices is more than any conventional therapy. The implantation of these devices is also costly that is estimated to limit the adoption and eventually hamper the market growth.
  • Lack of Skilled Medical Professionals
  • Disrupted Supply-Chain due to COVID-19

Ventricular Assist Devices Market: Key Insights

Base Year

2022

Forecast Year

2023-2033

CAGR

~9%

Base Year Market Size (2022)

~ USD 2.3 Billion

Forecast Year Market Size (2033)

~ USD 5.5Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

9.4%

Base Year Market Size (2024)

USD 2.77 billion

Forecast Year Market Size (2037)

USD 8.96 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 1410
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of ventricular assist devices is estimated at USD 2.98 billion.

The ventricular assist devices market size was valued at USD 2.77 billion in 2024 and is poised to cross USD 8.96 billion by the end of 2037, expanding at more than 9.4% CAGR during the forecast period i.e., between 2025-2037. Rising penetration of stroke and increasing prevalence of coronary artery disease will drive the market growth.

North America industry is predicted to hold largest revenue share by 2037, driven by increasing cases of cardiac arrests along with rising adoption of new technological devices, and growing agreements for collaborations and development by the key players in the region.

The major players in the market include Abbott Laboratories, Sun Medical Technology Research Corpï¼Å½, Berlin Heart GmbH, Abiomed, Inc., ReliantHeart, Inc., Jarvik Heart, Inc, LivaNova, Inc., Boston Scientific Corporation, Calon cardio-Technology Ltd., Medtronic plc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample